As an example of the sort of innovation needed, the NCI and other NIH institutes recently issued a SBIR contract solicitation in search of two new technologies???one for a new type of vaccine for preventing HIV infections and HIV-associated cancers, and the other for a new type of imaging to help optimize anti-angiogenic therapeutics. (A document detailing the solicitation is here.)